Loading term…
EMA revision (2025) to GVP Module XVI on risk minimization; adds guidance on effectiveness evaluation of risk minimization measures and pregnancy prevention programmes.
Evaluating effectiveness of a PPP via surveys and prescriber feedback.
EMA GVP Module XVI Rev 3 & Addendum II (2025)
Not implementing effectiveness studies for aRMMs as per addendum.
How does GVP XVI Addendum II affect your RMP and aRMM evaluation?